Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

568 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Power surge: supporting cells "fuel" cancer cell mitochondria.
Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Martinez-Outschoorn UE, et al. Cell Metab. 2012 Jan 4;15(1):4-5. doi: 10.1016/j.cmet.2011.12.011. Cell Metab. 2012. PMID: 22225869
Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice.
Bonuccelli G, Sotgia F, Capozza F, Gazzerro E, Minetti C, Lisanti MP. Bonuccelli G, et al. Cell Cycle. 2007 May 15;6(10):1242-8. doi: 10.4161/cc.6.10.4182. Epub 2007 May 27. Cell Cycle. 2007. PMID: 17495527
Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells.
Lamb R, Ozsvari B, Bonuccelli G, Smith DL, Pestell RG, Martinez-Outschoorn UE, Clarke RB, Sotgia F, Lisanti MP. Lamb R, et al. Oncotarget. 2015 Sep 8;6(26):21892-905. doi: 10.18632/oncotarget.5260. Oncotarget. 2015. PMID: 26323205 Free PMC article.
Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity.
Bonuccelli G, Peiris-Pages M, Ozsvari B, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Bonuccelli G, et al. Oncotarget. 2017 Feb 7;8(6):9868-9884. doi: 10.18632/oncotarget.14196. Oncotarget. 2017. PMID: 28039467 Free PMC article.
Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling.
Lamb R, Bonuccelli G, Ozsvári B, Peiris-Pagès M, Fiorillo M, Smith DL, Bevilacqua G, Mazzanti CM, McDonnell LA, Naccarato AG, Chiu M, Wynne L, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Lamb R, et al. Oncotarget. 2015 Oct 13;6(31):30453-71. doi: 10.18632/oncotarget.5852. Oncotarget. 2015. PMID: 26421711 Free PMC article.
Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells.
De Luca A, Fiorillo M, Peiris-Pagès M, Ozsvari B, Smith DL, Sanchez-Alvarez R, Martinez-Outschoorn UE, Cappello AR, Pezzi V, Lisanti MP, Sotgia F. De Luca A, et al. Oncotarget. 2015 Jun 20;6(17):14777-95. doi: 10.18632/oncotarget.4401. Oncotarget. 2015. PMID: 26087310 Free PMC article.
Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease.
Lamb R, Ozsvari B, Lisanti CL, Tanowitz HB, Howell A, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Lamb R, et al. Oncotarget. 2015 Mar 10;6(7):4569-84. doi: 10.18632/oncotarget.3174. Oncotarget. 2015. PMID: 25625193 Free PMC article.
Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer.
Monti D, Sotgia F, Whitaker-Menezes D, Tuluc M, Birbe R, Berger A, Lazar M, Cotzia P, Draganova-Tacheva R, Lin Z, Domingo-Vidal M, Newberg A, Lisanti MP, Martinez-Outschoorn U. Monti D, et al. Semin Oncol. 2017 Jun;44(3):226-232. doi: 10.1053/j.seminoncol.2017.10.001. Epub 2017 Oct 10. Semin Oncol. 2017. PMID: 29248134 Free PMC article.
Cigarette smoke metabolically promotes cancer, via autophagy and premature aging in the host stromal microenvironment.
Salem AF, Al-Zoubi MS, Whitaker-Menezes D, Martinez-Outschoorn UE, Lamb R, Hulit J, Howell A, Gandara R, Sartini M, Galbiati F, Bevilacqua G, Sotgia F, Lisanti MP. Salem AF, et al. Cell Cycle. 2013 Mar 1;12(5):818-25. doi: 10.4161/cc.23722. Epub 2013 Feb 6. Cell Cycle. 2013. PMID: 23388463 Free PMC article.
568 results
Jump to page